CSI Market
Sign In | Register

Medifast Inc (MED) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MED quarterly Cash Flow →
Looking at cash flow data from Medifast Inc through Dec 31 2021 provides insight into Dec 31 2025's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-18.67
Depreciation & amortization14.24
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories22.19
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets1.37
Share-based Compensation7.64
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Debt Securities Realized Gain Loss-3.31
Investment Income Net Amortization Of Discount And Premium-0.67
Equity Securities Fv Ni Unrealized Loss-
Equity Securities Fv Ni Unrealized Gain Loss-0.02
Operating Lease Expense Non Cash4.62
Income taxes4.86
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Income Taxes Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-23.91
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.57
Other Working Capital-2.06
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities6.86
Investing Activities
Capital Expenditures-5.61
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities82.09
Payments to Acquire Available-for-sale Securities, Debt-84.41
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-7.93
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.37
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-90.93
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents90.93
Proceeds From Stock Options Exercised Executives And Directors-
Payments For Repurchase Of Common Stock Not Yet Settled-
Proceeds From Stock Options Exercised Directors-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-0.20
Net Cash Flow from Financing Activities-0.56
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.25
Total Cash Flow-1.63
4 historic quarters locked

Sign in to unlock the full Medifast Inc cash flow history.

Sign In Create Free Account

About Medifast Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 17, 2026
  • Source: med-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-008656

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License